Undescribed diterpenes from Euphorbia mauritanica L. as modulators of the breast cancer resistance: Mechanistic and in silico studies
Phytochemistry · 2025
DOI: 10.1016/j.phytochem.2025.114418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2025. Verfasst von Ahmed F Essa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry of Natural Compounds Department, National Research Centre, 33 El Bohouth St, Dokki, Giza, 12622, Egypt. Hauptthemen laut MEDLINE: Euphorbia, Diterpenes, Drug Resistance, Neoplasm, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Research Centre, Academy of Scientific Research & Technology.
Abstract (Originalsprache)
As part of efforts to identify natural modulators of multi-drug-resistant breast cancer, Euphorbia mauritanica L. chloroform extract yielded four undescribed oxygenated diterpenes, including three nor-ent-abietanes, euphomauritanol C-E (1-3), and one polyacylated jatrophane, euphomauritanolide A (4), along with two knowns, helioscopinolide A (5) and enukokurin (6). The chemical structures and configurations of compounds were established by combination of HRMS, FTIR, and NMR spectroscopic tools along with experimental and calculated TDDFT-ECD. The cytotoxicity evaluation of isolated compounds against the MCF-7ADR revealed 4 and 2 are the most potent with IC50 values of 3.2 ± 0.58 and 4.67 ± 0.29 μM, respectively. Co-administration of compounds 4 and 2 with DOX improved its cytotoxic effect, with a combination index value of 0.41 for 4, indicating a synergistic effect. Mechanistically, 4 modulated DOX anticancer properties via potentiating DOX-induced Go/G1 cell cycle arrest rather than G2M arrest of DOX alone and shifting the cell death of DOX to be mainly apoptotic cell death. Furthermore, 4 alone and combined with DOX showed promising anti-migratory effects against MCF-7ADR. In conclusion, 4 showed promising co-chemotherapeutic effects to the DOX against MCF-7ADR, indicating that this compound possesses potential as an auspicious lead chemical to target breast cancer cells resistant to doxorubicin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry of Natural Compounds Department, National Research Centre, 33 El Bohouth St, Dokki, Giza, 12622, Egypt.
- Pharmacology Department, Medical and Clinical Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.
- Chemistry of Natural Compounds Department, National Research Centre, 33 El Bohouth St, Dokki, Giza, 12622, Egypt; Academy of Scientific Research and Technology (ASRT), 101 Kasr El Ainy St. Kasr El Ainy, 11516, Cairo, Eg…
Förderung
- National Research Centre
- Academy of Scientific Research & Technology
Zitieren
APA
Essa, A. F., Elghonemy, M. M., Taher, R. F., Allam, R. M., & Elshamy, A. I. (2025). Undescribed diterpenes from Euphorbia mauritanica L. as modulators of the breast cancer resistance: Mechanistic and in silico studies. Phytochemistry. https://doi.org/10.1016/j.phytochem.2025.114418
Vancouver
Essa AF, Elghonemy MM, Taher RF, Allam RM, Elshamy AI. Undescribed diterpenes from Euphorbia mauritanica L. as modulators of the breast cancer resistance: Mechanistic and in silico studies. Phytochemistry. 2025. doi:10.1016/j.phytochem.2025.114418
BibTeX
@article{Essa2025,
author = {Essa, Ahmed F and Elghonemy, Mai M and Taher, Rehab F and Allam, Rasha M and Elshamy, Abdelsamed I},
title = {Undescribed diterpenes from Euphorbia mauritanica L. as modulators of the breast cancer resistance: Mechanistic and in silico studies},
journal = {Phytochemistry},
year = {2025},
doi = {10.1016/j.phytochem.2025.114418}
}
EUVIMED